Omega Stock Probability of Future Stock Price Finishing Over 5.13

OMGA
 Stock
  

USD 5.13  0.44  7.90%   

Omega Therapeutics' future price is the expected price of Omega Therapeutics instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Omega Therapeutics performance during a given time horizon utilizing its historical volatility.
  
Omega Therapeutics' implied volatility is one of the determining factors in the pricing options written on Omega Therapeutics. Implied volatility approximates the future value of Omega Therapeutics based on the option's current value. Options with high implied volatility have higher premiums and can be used to hedge the downside of investing in Omega Therapeutics over a specific time period. For example, 2022-10-21 CALL at $5.0 is a CALL option contract on Omega Therapeutics' common stock with a strick price of 5.0 expiring on 2022-10-21. The contract was last traded on 2022-09-15 at 12:55:44 for $1.25 and, as of today, has 21 days remaining before the expiration. The option is currently trading at a bid price of $0.45, and an ask price of $1.1. The implied volatility as of the 30th of September is 146.0094. View All Omega options

Closest to current price Omega long CALL Option Payoff at Expiration

Please check Omega Therapeutics Backtesting, Omega Therapeutics Valuation, Omega Therapeutics Correlation, Omega Therapeutics Hype Analysis, Omega Therapeutics Volatility, Omega Therapeutics History as well as Omega Therapeutics Performance. Please specify Omega Therapeutics time horizon, a valid symbol (red box) and a target price (blue box) you would like Omega Therapeutics odds to be computed.

Omega Therapeutics Target Price Odds to finish over 5.13

The tendency of Omega Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 5.13 90 days 5.13 
about 43.64
Based on a normal probability distribution, the odds of Omega Therapeutics to move above the current price in 90 days from now is about 43.64 (This Omega Therapeutics probability density function shows the probability of Omega Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days the stock has the beta coefficient of 1.05 . This indicates Omega Therapeutics market returns are sensitive to returns on the market. As the market goes up or down, Omega Therapeutics is expected to follow. Additionally The company has an alpha of 0.6637, implying that it can generate a 0.66 percent excess return over DOW after adjusting for the inherited market risk (beta).
   Omega Therapeutics Price Density   
       Price  

Predictive Modules for Omega Therapeutics

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Omega Therapeutics. Regardless of method or technology, however, to accurately forecast the stock or bond market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Omega Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Omega Therapeutics in the context of predictive analytics.
Hype
Prediction
LowEstimated ValueHigh
0.255.0411.58
Details
Intrinsic
Valuation
LowReal ValueHigh
0.265.2611.80
Details
Naive
Forecast
LowNext ValueHigh
0.094.2710.81
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
4.775.586.38
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Omega Therapeutics. Your research has to be compared to or analyzed against Omega Therapeutics' peers to derive any actionable benefits. When done correctly, Omega Therapeutics' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Omega Therapeutics.

Omega Therapeutics Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Omega Therapeutics is not an exception. The market had few large corrections towards the Omega Therapeutics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Omega Therapeutics, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Omega Therapeutics within the framework of very fundamental risk indicators.
α
Alpha over DOW
0.66
β
Beta against DOW1.05
σ
Overall volatility
0.75
Ir
Information ratio 0.1

Omega Therapeutics Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Omega Therapeutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Omega Therapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Omega Therapeutics is way too risky over 90 days horizon
Omega Therapeutics appears to be risky and price may revert if volatility continues
The company reported the previous year's revenue of 412 K. Net Loss for the year was (74.96 M) with loss before overhead, payroll, taxes, and interest of (47.72 M).
Omega Therapeutics currently holds about 200.8 M in cash with (70.41 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.2.
Over 91.0% of the company shares are owned by institutional investors
Latest headline from www.benzinga.com: Omega Therapeutics to Participate in Two Upcoming Investor Conferences - Omega Therapeutics - Benzinga

Omega Therapeutics Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Omega Stock often depends not only on the future outlook of the current and potential Omega Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Omega Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
Shares Percent Shares Out1.13%
Short Percent Of Float2.57%
Float Shares17.52M
Shares Short Prior Month1.13M
Average Daily Volume Last 10 Day100.45k
Average Daily Volume In Three Month90.33k
Date Short Interest15th of July 2022

Omega Therapeutics Technical Analysis

Omega Therapeutics' future price can be derived by breaking down and analyzing its technical indicators over time. Omega Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Omega Therapeutics. In general, you should focus on analyzing Omega Stock price patterns and their correlations with different microeconomic environments and drivers.

Omega Therapeutics Predictive Forecast Models

Omega Therapeutics time-series forecasting models is one of many Omega Therapeutics' stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Omega Therapeutics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about Omega Therapeutics

Checking the ongoing alerts about Omega Therapeutics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Omega Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Omega Therapeutics is way too risky over 90 days horizon
Omega Therapeutics appears to be risky and price may revert if volatility continues
The company reported the previous year's revenue of 412 K. Net Loss for the year was (74.96 M) with loss before overhead, payroll, taxes, and interest of (47.72 M).
Omega Therapeutics currently holds about 200.8 M in cash with (70.41 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.2.
Over 91.0% of the company shares are owned by institutional investors
Latest headline from www.benzinga.com: Omega Therapeutics to Participate in Two Upcoming Investor Conferences - Omega Therapeutics - Benzinga
Please check Omega Therapeutics Backtesting, Omega Therapeutics Valuation, Omega Therapeutics Correlation, Omega Therapeutics Hype Analysis, Omega Therapeutics Volatility, Omega Therapeutics History as well as Omega Therapeutics Performance. Note that the Omega Therapeutics information on this page should be used as a complementary analysis to other Omega Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.

Complementary Tools for Omega Stock analysis

When running Omega Therapeutics price analysis, check to measure Omega Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Omega Therapeutics is operating at the current time. Most of Omega Therapeutics' value examination focuses on studying past and present price action to predict the probability of Omega Therapeutics' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Omega Therapeutics' price. Additionally, you may evaluate how the addition of Omega Therapeutics to your portfolios can decrease your overall portfolio volatility.
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Go
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Go
Transaction History
View history of all your transactions and understand their impact on performance
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Is Omega Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Omega Therapeutics. If investors know Omega will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Omega Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Omega Therapeutics is measured differently than its book value, which is the value of Omega that is recorded on the company's balance sheet. Investors also form their own opinion of Omega Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Omega Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Omega Therapeutics' market value can be influenced by many factors that don't directly affect Omega Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Omega Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine Omega Therapeutics value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Omega Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.